These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1421100)

  • 21. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
    Zhang RL; Chopp M; Zhang ZG; Divine G
    J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
    Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
    Haelewyn B; Risso JJ; Abraini JH
    J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model.
    Vanderschueren S; Van Vlaenderen I; Collen D
    Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of lesion side on acute stroke treatment.
    Di Legge S; Fang J; Saposnik G; Hachinski V
    Neurology; 2005 Jul; 65(1):81-6. PubMed ID: 16009890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke.
    Yenari MA; de Crespigny A; Palmer JT; Roberts S; Schrier SL; Albers GW; Moseley ME; Steinberg GK
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):401-11. PubMed ID: 9143222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant tissue plasminogen activator attenuates basal lamina antigen loss after experimental focal cerebral ischemia.
    Grobholz K; Burggraf D; Martens KH; Wunderlich N; Pichler M; Hamann FG
    Neurol Res; 2005 Mar; 27(2):212-7. PubMed ID: 15829186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early embolic events complicating intravenous thrombolysis for acute ischemic stroke.
    Chou PS; Lin CH; Chao HL; Chao AC
    Am J Emerg Med; 2012 Nov; 30(9):2079.e3-5. PubMed ID: 22205004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
    Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
    Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined X-ray angiography and diffusion-perfusion MRI for studying stroke evolution after rt-PA treatment in rats.
    Busch E; Beaulieu C; de Crespigny A; Kreischer S; Diener HC; Moseley ME
    Brain Res; 2002 Oct; 953(1-2):112-8. PubMed ID: 12384244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats.
    Aldandashi S; Noor R; Wang CX; Uddin G; Shuaib A
    Exp Neurol; 2007 Jun; 205(2):563-8. PubMed ID: 17466978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
    Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
    Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.